Susceptibility to human cancer: From the perspective of a pathologist

Pathology International

Volumn 66, Issue 7, 2016, Pages 359-368

  Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adductome; adductomics; cancer susceptibility; exposome; gene environmental interaction; genetic polymorphism; molecular epidemiology

Indexed keywords

8 HYDROXYGUANINE; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; DNA BASE; DNA GLYCOSYLTRANSFERASE; THYMINE DNA GLYCOSYLASE;

ALLELE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA ADDUCT; DNA REPAIR; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GASTRIC MUCOSA; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIPID PEROXIDATION; MICROSATELLITE INSTABILITY; MOLECULAR EPIDEMIOLOGY; NEOPLASM; PRIORITY JOURNAL; REVIEW; SMOKING; STOMACH CANCER;

EID: 84977530534     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12418     Document Type: Review

References (100)

1. Ayesh R, Idle JR, Ritchie JC et al. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 1984; 312: 169–70.
2. Idle J. Pharmacogenetics. Enigmatic variations Nature 1988; 331: 391–2.
3. Gonzalez FJ, Skoda RC, Kimura S et al. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988; 331: 442–6.
4. Sugimura H, Caporaso NE, Modali RV et al. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Cancer Res 1990; 50: 1857–62.
5. Yamada H, Shinmura K, Yamamura Y et al. Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer. Int J Cancer 2009; 125: 973–6.
6. Sugita K, Yamamoto O, Suenaga Y. Seven Cases of Radiation-lnduced Cutaneous Squamous Cell Carcinoma. J UOEH 2000; 22: 259–67.
7. Laurent S, Franchimont D, Coppens JP et al. Familial adenomatous polyposis: clinical presentation, detection and surveillance. Acta Gastroenterol Belg 2011; 74: 415–20.
8. Tao H, Shinmura K, Yamada H et al. Identification of 5 novel germline APC mutations and characterization of clinical phenotypes in Japanese patients with classical and attenuated familial adenomatous polyposis. BMC Res Notes 2010; 3: 305.
9. Charlton A, Blair V, Shaw D et al. Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004; 53: 814–20.
10. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978; 32: 303–13.
11. Bell DW, Gore I, Okimoto RA et al. Inherited susceptibility to lung cancer may be associated with the T790 M drug resistance mutation in EGFR. Nat Genet 2005; 37: 1315–6.
12. Gazdar A, Robinson L, Oliver D et al. Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790 M mutations. J Thorac Oncol 2014; 9: 456–63.
13. Kenfield SA, Wei EK, Stampfer MJ et al. Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control 2008; 17: 198–204.
14. Lubin JH, Blot WJ. Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst 1984; 73: 383–9.
15. Sugimura H, Watanabe S, Tsugane S et al. Case–control study on histologically determined multiple primary lung cancer. J Natl Cancer Inst 1987; 79: 435–41.
16. Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258–61.
17. Shinmura K, Sugimura H, Naito Y et al. Frequent co-occurrence of mutator phenotype in synchronous, independent multiple cancers of the stomach. Carcinogenesis 1995; 16: 2989–93.
18. Shinmura K, Yin W, Isogaki J et al. Stage-dependent evaluation of microsatellite instability in gastric carcinoma with familial clustering. Cancer Epidemiol Biomarkers Prev 1997; 6: 693–7.
19. Guo RJ, Arai H, Kitayama Y et al. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa. Pathol Int 2001; 51: 240–7.
20. Song JP, Kitayama Y, Igarashi H et al. Centromere numerical abnormality in the papillary, papillotubular type of early gastric cancer, a further characterization of a subset of gastric cancer. Int J Oncol 2002; 21: 1205–11.
21. Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci 2005; 96: 206–11.
22. Li Y, Liang J, Hou P. Hypermethylation in gastric cancer. Clin Chim Acta 2015; 448: 124–32.
23. Song YS, Kim Y, Cho NY et al. Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication. Gastric Cancer 2015; 19: 98–106.
24. Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics 2015; 7: 475–86.
25. Caldas C, Carneiro F, Lynch HT et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999; 36: 873–80.
26. Shinmura K, Kohno T, Takahashi M et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999; 20: 1127–31.
27. Aoki M, Yamamoto K, Noshiro H et al. A full genome scan for gastric cancer. J Med Genet 2005; 42: 83–7.
28. Aoki M, Yamamoto K, Ohyama S et al. A genetic variant in the gene encoding the stress70 protein chaperone family member STCH is associated with gastric cancer in the Japanese population. Biochem Biophys Res Commun 2005; 335: 566–74.
29. Sakamoto H, Yoshimura K, Saeki N et al. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 2008; 40: 730–40.
30. Saeki N, Saito A, Choi IJ et al. A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 2011; 140: 892–902.
31. Yamada H, Shinmura K, Ito H et al. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Sci 2011; 102: 1782–8.
32. Sugimoto S, Yamada H, Takahashi M et al. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer 2014; 17: 745–9.
33. Yamada H, Sakamoto H, Sugimura H. Sexy Small Copy Numbers in Hereditary Gastric Carcinogenesis. Gastrointestinal & Digestive System 2014; 4: 205.
34. Perera FP, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis 1982; 35: 581–600.
35. Sugimura H, Weston A, Caporaso NE et al. Biochemical and molecular epidemiology of cancer. Biomed Environ Sci 1991; 4: 73–92.
36. Krontiris TG, DiMartino NA, Colb M et al. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature 1985; 313: 369–74.
37. Kawajiri K, Nakachi K, Imai K et al. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990; 263: 131–3.
38. Weston A, Vineis P, Caporaso NE et al. Racial variation in the distribution of Ha-ras-1 alleles. Mol Carcinog 1991; 4: 265–8.
39. Kato S, Shields PG, Caporaso NE et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992; 52: 6712–5.
40. Gao C, Takezaki T, Wu J et al. Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev 2002; 11: 29–34.
41. Lee KM, Kang D, Clapper ML et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 2008; 17: 1120–6.
42. Smits KM, Benhamou S, Garte S et al. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer 2004; 110: 266–70.
43. Vineis P, Veglia F, Benhamou S et al. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003; 104: 650–7.
44. Le Marchand L, Guo C, Benhamou S et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 2003; 14: 339–46.
45. Sugimura H, Wakai K, Genka K et al. Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case–control study in Okinawa. Cancer Epidemiol Biomarkers Prev 1998; 7: 413–7.
46. Ariyoshi N, Miyamoto M, Umetsu Y et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11: 890–4.
47. Kamataki T, Nunoya K, Sakai Y et al. Genetic polymorphism of CYP2A6 in relation to cancer. Mutat Res 1999; 428: 125–30.
48. Hosono H, Kumondai M, Arai T et al. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers. Drug Metab Pharmacokinet 2015; 30: 263–8.
49. Wassenaar CA, Ye Y, Cai Q et al. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers–findings from two independent populations. Carcinogenesis 2015; 36: 99–103.
50. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res 2005; 577: 275–83.
51. Al-Tassan N, Chmiel NH, Maynard J et al. Inherited variants of MYH associated with somatic G:C– > T:A mutations in colorectal tumors. Nat Genet 2002; 30: 227–32.
52. Sakiyama T, Kohno T, Mimaki S et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 2005; 114: 730–7.
53. Cavalieri EL, Stack DE, Devanesan PD et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 1997; 94: 10937–42.
54. Phillips DH. DNA adducts as markers of exposure and risk. Mutat Res 2005; 577: 284–92.
55. De Bont R, van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 2004; 19: 169–85.
56. Sugimura H, Tao H, Suzuki M et al. Genetic susceptibility to lung cancer. Front Biosci (Schol Ed) 2011; 3: 1463–77.
57. Chou PH, Kageyama S, Matsuda S et al. Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chem Res Toxicol 2010; 23: 1442–8.
58. Kasai H, Hayami H, Yamaizumi Z et al. Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. Nucleic Acids Res 1984; 12: 2127–36.
59. Kuchino Y, Mori F, Kasai H et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987; 327: 77–9.
60. Rosenquist TA, Zharkov DO, Grollman AP. Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci U S A 1997; 94: 7429–34.
61. Aburatani H, Hippo Y, Ishida T et al. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res 1997; 57: 2151–6.
62. Kohno T, Shinmura K, Tosaka M et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219–25.
63. Sugimura H, Hamada GS, Suzuki I et al. CYP1A1 and CYP2E1 polymorphism and lung cancer, case–control study in Rio de Janeiro, Brazil. Pharmacogenetics 1995; 5 Spec No: S145–8.
64. Goto M, Shinmura K, Igarashi H et al. Altered expression of the human base excision repair gene NTH1 in gastric cancer. Carcinogenesis 2009; 30: 1345–52.
65. Weren RD, Ligtenberg MJ, Kets CM et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet 2015; 47: 668–71.
66. Svoboda P, Ko SH, Cho B et al. Neopterin, a marker of immune response, and 8-hydroxy-2′-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine. Anal Biochem 2008; 383: 236–42.
67. Tamae K, Kawai K, Yamasaki S et al. Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine. Cancer Sci 2009; 100: 715–21.
68. Loft S, Svoboda P, Kawai K et al. Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med 2012; 52: 167–72.
69. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 91–102.
70. Takezaki T, Gao CM, Wu JZ et al. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 2002; 99: 624–7.
71. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 2006; 444: 444–54.
72. Zuo L, Saba L, Wang K et al. Exome-wide association study of replicable nonsynonymous variants conferring risk for alcohol dependence. J Stud Alcohol Drugs 2013; 74: 622–5.
73. Chen MM, Crous-Bou M, Setiawan VW et al. Exome-wide association study of endometrial cancer in a multiethnic population. PLoS One 2014; 9.e97045
74. Kozlitina J, Smagris E, Stender S et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2014; 46: 352–6.
75. Kawai Y, Mimori T, Kojima K et al. Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals. J Hum Genet 2015; 60: 581–7.
76. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1847–50.
77. Wild CP. The exposome: from concept to utility. Int J Epidemiol 2012; 41: 24–32.
78. Flood VM, Wen LM, Hardy LL et al. Reliability and validity of a short FFQ for assessing the dietary habits of 2-5-year-old children, Sydney, Australia. Public Health Nutr 2014; 17: 498–509.
79. Farajian P, Bountziouka V, Risvas G et al. Anthropometric, lifestyle and parental characteristics associated with the prevalence of energy intake misreporting in children: the GRECO (Greek Childhood Obesity) study. Br J Nutr 2015; 113: 1120–8.
80. Tokuhata GK. Smoking Habits in Lung-Cancer Proband Families and Comparable Control Families. J Natl Cancer Inst 1963; 31: 1153–71.
81. Bierut LJ. Genetic variation that contributes to nicotine dependence. Pharmacogenomics 2007; 8: 881–3.
82. Hung RJ, McKay JD, Gaborieau V et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633–7.
83. Sato N, Sato T, Nozawa A et al. Assessment Scales for Nicotine Addiction. Journal of Addiction Research & Therapy 2012; S1: 008.
84. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3: 235–41.
85. Sato N, Kageyama S, Chen R et al. Association between neuropeptide Y receptor 2 polymorphism and the smoking behavior of elderly Japanese. J Hum Genet 2010; 55: 755–60.
86. Sato N, Kageyama S, Chen R et al. Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese. Psychiatr Genet 2010; 20: 135–6.
87. Ella E, Sato N, Nishizawa D et al. Association between dopamine beta hydroxylase rs5320 polymorphism and smoking behaviour in elderly Japanese. J Hum Genet 2012; 57: 385–90.
88. Kobayashi M, Hanaoka T, Tsugane S. Validity of a self-administered food frequency questionnaire in the assessment of heterocyclic amine intake using 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) levels in hair. Mutat Res 2007; 630: 14–9.
89. Iwasaki M, Mukai T, Takachi R et al. Validity of a self-administered food frequency questionnaire in the estimation of heterocyclic aromatic amines. Cancer Causes Control 2014; 25: 1015–28.
90. Kanaly RA, Hanaoka T, Sugimura H et al. Development of the adductome approach to detect DNA damage in humans. Antioxid Redox Signal 2006; 8: 993–1001.
91. Balbo S, Hecht SS, Upadhyaya P et al. Application of a high-resolution mass-spectrometry-based DNA adductomics approach for identification of DNA adducts in complex mixtures. Anal Chem 2014; 86: 1744–52.
92. Balbo S, Turesky RJ, Villalta PW. DNA adductomics. Chem Res Toxicol 2014; 27: 356–66.
93. Matsuda T, Tao H, Goto M et al. Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis 2013; 34: 121–7.
94. Ishino K, Kato T, Kato M et al. Comprehensive DNA adduct analysis reveals pulmonary inflammatory response contributes to genotoxic action of magnetite nanoparticles. Int J Mol Sci 2015; 16: 3474–92.
95. Kawai K, Kawasaki Y, Kubota Y et al. Identification of octenal-related dA and dC adducts formed by reactions with a hemin-omega-6-fat peroxidation model system. Chem Res Toxicol 2013; 26: 1554–60.
96. Goto M, Shinmura K, Matsushima Y et al. Human DNA glycosylase enzyme TDG repairs thymine mispaired with exocyclic etheno-DNA adducts. Free Radic Biol Med 2014; 76: 136–46.
97. Du C, Kurabe N, Matsushima Y et al. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer. Gastric Cancer 2015; 18: 516–25.
98. Ogino S, Chan AT, Fuchs CS et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397–411.
99. Shibata T. Cancer genomics and pathology: all together now. Pathol Int 2012; 62: 647–59.
100. Matsuda Y, Semi K, Yamada Y. Application of iPS cell technology to cancer epigenome study: uncovering the mechanism of cell status conversion for drug resistance in tumor. Pathol Int 2014; 64: 299–308.